Search

Your search keyword '"Devouassoux-Shisheboran, M."' showing total 343 results
Start Over Author "Devouassoux-Shisheboran, M."
343 results on '"Devouassoux-Shisheboran, M."'

3. Tratamiento médico de los cánceres epiteliales de ovario

Author

Corbaux, P., Sajous, C., Péron, J., Bakrin, N., Bolze, P.-A., Glehen, O., Kepenekian, V., Gertych, W., Philip, C.-A., Chene, G., Devouassoux-Shisheboran, M., Lopez, J., Pinson, S., Giraud, S., Rousset, P., Bruyas, A., Duplomb, S., Tigaud, J.-D., Bonnin, N., Freyer, G., and You, B.

Published
2022
Full Text
View/download PDF

4. Potential histological discordance revealed by second review in the national rare gynecological cancer network (TMRG)

Author

Henno, S., Jeanne, C., Rouge, T. De La Motte, Genestie, C., Treilleux, I., Croce, S., Just, P.A., Le Frere-Belda, M.A., Guinaudeau, E., Penault-Llorca, F., Arnould, L., Mery-Lamarche, E., Leroux, A., Lemaire, A.S., Averous, G., Renaud, O., Charafe-Jauffret, E., Bonneau, C., Leaha, C., Ray-Coquard, I., and Devouassoux-Shisheboran, M.

Published
2022
Full Text
View/download PDF

6. Tumeurs frontières de l’ovaire. Recommandations pour la pratique clinique du CNGOF – Texte court

Author

Bourdel, N., Huchon, C., Cendos, A.W., Azaïs, H., Bendifallah, S., Bolze, P.A., Brun, J.L., Canlorbe, G., Chauvet, P., Chéreau, E., Courbiere, B., De La Motte Rouge, T., Devouassoux-Shisheboran, M., Eymerit-Morin, C., Fauvet, R., Gauroy, E., Gauthier, T., Grynberg, M., Koskas, M., Larouzee, E., Lecointre, L., Levêque, J., Margueritte, F., Mathieu D’argent, E., Nyangoh-Timoh, K., Ouldamer, L., Raad, J., Raimond, E., Ramanah, R., Rolland, L., Rousset, P., Rousset-Jablonski, C., Thomassin-Naggara, I., Uzan, C., Zilliox, M., and Daraï, E.

Published
2020
Full Text
View/download PDF

8. Management of epithelial cancer of the ovary, fallopian tube, primary peritoneum. Long text of the joint French clinical practice guidelines issued by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY, endorsed by INCa. (Part 2: systemic, intraperitoneal treatment, elderly patients, fertility preservation, follow-up)

Author

Lavoue, V., Huchon, C., Akladios, C., Alfonsi, P., Bakrin, N., Ballester, M., Bendifallah, S., Bolze, P.A., Bonnet, F., Bourgin, C., Chabbert-Buffet, N., Collinet, P., Courbiere, B., De la motte rouge, T., Devouassoux-Shisheboran, M., Falandry, C., Ferron, G., Fournier, L., Gladieff, L., Golfier, F, Gouy, S., Guyon, F., Lambaudie, E, Leary, A., Lecuru, F., Lefrere-Belda, M.A., Leblanc, E., Lemoine, A, Narducci, F., Ouldamer, L., Pautier, P., Planchamp, F., Pouget, N., Ray-Coquard, I., Rousset-Jablonski, C., Senechal-Davin, C., Touboul, C., Thomassin-Naggara, I., Uzan, C., You, B., and Daraï, E.

Published
2019
Full Text
View/download PDF

9. Management of epithelial cancer of the ovary, fallopian tube, and primary peritoneum. Long text of the Joint French Clinical Practice Guidelines issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and endorsed by INCa. Part 1: Diagnostic exploration and staging, surgery, perioperative care, and pathology

Author

Lavoue, V., Huchon, C., Akladios, C., Alfonsi, P., Bakrin, N., Ballester, M., Bendifallah, S., Bolze, P.A., Bonnet, F., Bourgin, C., Chabbert-Buffet, N., Collinet, P., Courbiere, B., De la motte rouge, T., Devouassoux-Shisheboran, M., Falandry, C., Ferron, G., Fournier, L., Gladieff, L., Golfier, F., Gouy, S., Guyon, F., Lambaudie, E., Leary, A., Lecuru, F., Lefrere-Belda, M.A., Leblanc, E., Lemoine, A., Narducci, F., Ouldamer, L., Pautier, P., Planchamp, F., Pouget, N., Ray-Coquard, I., Rousset-Jablonski, C., Senechal-Davin, C., Touboul, C., Thomassin-Naggara, I., Uzan, C., You, B., and Daraï, E.

Published
2019
Full Text
View/download PDF

10. ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease

Author

Baert, T., Banerjee, S., Belaroussi, I., Blecharz, P., Bruchim, I., Cibula, D., Colombo, N., Concin, N., Davidson, B., Dashora, A., Devouassoux-Shisheboran, M., du Bois, A., Ferrero, A., Glasspool, R., González-Martin, A., Heinzelmann-Schwarz, V., Joly, F., Kim, J.W., Kridelka, F., Ledermann, J., Lorusso, D., Mahner, S., McCluggage, W.G., McNeish, I., Mikami, M., Mirza, M.R., Morice, P., Nicum, S., Olbrecht, S., O’Donnell, D.M., Pautier, P., Planchamp, F., Pignata, S., Querleu, D., Ray-Coquard, I., Rodolakis, A., Sehouli, J., Selcukbiricik, F., Sessa, C., Singh, N., Tan, D.S.P., Timmerman, D., Tognon, G., van der Velden, J., Vergote, I., Witteveen, P.O., and Zeimet, A.G.

Published
2019
Full Text
View/download PDF

11. Management of epithelial cancer of the ovary, fallopian tube, and primary peritoneum. Short text of the French Clinical Practice Guidelines issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and endorsed by INCa

Author

Lavoue, V., Huchon, C., Akladios, C., Alfonsi, P., Bakrin, N., Ballester, M., Bendifallah, S., Bolze, P.A., Bonnet, F., Bourgin, C., Chabbert-Buffet, N., Collinet, P., Courbiere, B., De la motte rouge, T., Devouassoux-Shisheboran, M., Falandry, C., Ferron, G., Fournier, L., Gladieff, L., Golfier, F., Gouy, S., Guyon, F., Lambaudie, E., Leary, A., Lecuru, F., Lefrere-Belda, M.A., Leblanc, E., Lemoine, A., Narducci, F., Ouldamer, L., Pautier, P., Planchamp, F., Pouget, N., Ray-Coquard, I., Rousset-Jablonski, C., Senechal-Davin, C., Touboul, C., Thomassin-Naggara, I., Uzan, C., You, B., and Daraï, E.

Published
2019
Full Text
View/download PDF

13. Biopathologie des carcinomes ovariens des stades précoces et avancés. Article rédigé sur la base de la recommandation nationale de bonnes pratiques cliniques en cancérologie intitulée « Conduites à tenir initiales devant des patientes atteintes d’un cancer épithélial de l’ovaire » élaborée par FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY sous l’égide du CNGOF et labellisée par l’INCa

Author

Devouassoux-Shisheboran, M., Le Frère-Belda, M.-A., and Leary, A.

Published
2019
Full Text
View/download PDF

14. Partie 2 rédigée à partir de la synthèse de la recommandation nationale de bonnes pratiques cliniques intitulée « Conduites à tenir initiales devant des patientes atteintes d’un cancer épithélial de l’ovaire » élaborée par FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY et labélisée par l’INCa. (Traitement systémique et intrapéritonéal, personnes âgées, préservation de la fertilité et suivi)

Author

Lavoué, V., Huchon, C., Akladios, C., Alfonsi, P., Bakrin, N., Ballester, M., Bendifallah, S., Bolze, P.A., Bonnet, F., Bourgin, C., Chabbert-Buffet, N., Collinet, P., Courbiere, B., De la Motte Rouge, T., Devouassoux-Shisheboran, M., Falandry, C., Ferron, G., Fournier, L., Gladieff, L., Golfier, F., Gouy, S., Guyon, F., Lambaudie, E., Leary, A., Lécuru, F., Lefrère-Belda, M.A., Leblanc, E., Lemoine, A., Narducci, F., Ouldamer, L., Pautier, P., Planchamp, F., Pouget, N., Ray-Coquard, I., Rousset-Jablonski, C., Sénéchal-Davin, C., Touboul, C., Thomassin-Naggara, I., Uzan, C., You, B., and Daraï, E.

Published
2019
Full Text
View/download PDF

15. Partie 1 rédigée sur la base de la recommandation nationale de bonnes pratiques cliniques en cancérologie intitulée « Conduites à tenir initiales devant des patientes atteintes d’un cancer épithélial de l’ovaire » élaborée par FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY et labélisée par l’INCa. (Explorations diagnostiques et bilan d’extension, chirurgie, soins périopératoires et anatomopathologie)

Author

Lavoué, V., Huchon, C., Akladios, C., Alfonsi, P., Bakrin, N., Ballester, M., Bendifallah, S., Bolze, P.A., Bonnet, F., Bourgin, C., Chabbert-Buffet, N., Collinet, P., Courbiere, B., De la Motte Rouge, T., Devouassoux-Shisheboran, M., Falandry, C., Ferron, G., Fournier, L., Gladieff, L., Golfier, F., Gouy, S., Guyon, F., Lambaudie, E., Leary, A., Lécuru, F., Lefrère-Belda, M.A., Leblanc, E., Lemoine, A., Narducci, F., Ouldamer, L., Pautier, P., Planchamp, F., Pouget, N., Ray-Coquard, I., Rousset-Jablonski, C., Sénéchal-Davin, C., Touboul, C., Thomassin-Naggara, I., Uzan, C., You, B., and Daraï, E.

Published
2019
Full Text
View/download PDF

16. Enfermedades trofoblásticas gestacionales: molas hidatiformes

Author

Bolze, P.-A., Provost, M., Massardier, J., Hajri, T., Descargues, P., Msika, A., Devouassoux-Shisheboran, M., Allias, F., Gaillot Durand, L., Patrier, S., Rousset, P., Tordo, J., Vlaeminck, V., Touraine, R., Lotz, J.-P., You, B., Massoud, M., and Golfier, F.

Abstract

Las enfermedades trofoblásticas gestacionales forman un conjunto heterogéneo de patologías infrecuentes. Agrupan patologías benignas (principalmente las molas hidatiformes) y los tumores trofoblásticos gestacionales. Las molas son el resultado de una anomalía de fecundación que origina un exceso de cromosomas paternos. Los tumores trofoblásticos gestacionales son el resultado de una transformación neoplásica de células del trofoblasto de un embarazo, independientemente de su naturaleza: embarazo molar (lo más frecuente), aborto o embarazo normal. El reto del tratamiento de las enfermedades trofoblásticas debe responder a varios problemas: garantizar la mejor supervivencia preservando la fertilidad de estas mujeres en edad de procrear.

Published
2024
Full Text
View/download PDF

17. Gynecological Carcinosarcomas

Author

Berton-Rigaud, D., Frenel, J. S., Devouassoux-Shisheboran, M., Ray-Coquard, I., Pujade-Lauraine, Eric, editor, Ray-Coquard, Isabelle, editor, and Lécuru, Fabrice, editor

Published
2017
Full Text
View/download PDF

18. The immune microenvironment of HPV-negative oral squamous cell carcinoma from never-smokers and never-drinkers patients suggests higher clinical benefit of IDO1 and PD1/PD-L1 blockade

Author

Foy, J.-P., Bertolus, C., Michallet, M.-C., Deneuve, S., Incitti, R., Bendriss-Vermare, N., Albaret, M.-A., Ortiz-Cuaran, S., Thomas, E., Colombe, A., Py, C., Gadot, N., Michot, J.-P., Fayette, J., Viari, A., Van den Eynde, B., Goudot, P., Devouassoux-Shisheboran, M., Puisieux, A., Caux, C., Zrounba, P., Lantuejoul, S., and Saintigny, P.

Published
2017
Full Text
View/download PDF

28. Les grossesses môlaires

Author

Massardier, J., Schott-Pethelaz, A. M., Hajri, T., Allias, F., Devouassoux-Shisheboran, M., Sanlaville, D., Trillet-Lenoir, V., Guastalla, J. -P., Raudrant, D., and Golfier, F.

Published
2011
Full Text
View/download PDF

32. Borderline ovarian tumors: Guidelines from the French national college of obstetricians and gynecologists (CNGOF)

Author

Bourdel, N., primary, Huchon, C., additional, Abdel Wahab, C., additional, Azaïs, H., additional, Bendifallah, S., additional, Bolze, P.A., additional, Brun, J.L., additional, Canlorbe, G., additional, Chauvet, P., additional, Chereau, E., additional, Courbiere, B., additional, De La Motte Rouge, T., additional, Devouassoux-Shisheboran, M., additional, Eymerit-Morin, C., additional, Fauvet, R., additional, Gauroy, E., additional, Gauthier, T., additional, Grynberg, M., additional, Koskas, M., additional, Larouzee, E., additional, Lecointre, L., additional, Levêque, J., additional, Margueritte, F., additional, Mathieu D’argent, E., additional, Nyangoh-Timoh, K., additional, Ouldamer, L., additional, Raad, J., additional, Raimond, E., additional, Ramanah, R., additional, Rolland, L., additional, Rousset, P., additional, Rousset-Jablonski, C., additional, Thomassin-Naggara, I., additional, Uzan, C., additional, Zilliox, M., additional, and Daraï, E., additional

Published
2021
Full Text
View/download PDF

37. ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease

Author

Colombo, N., primary, Sessa, C., additional, du Bois, A., additional, Ledermann, J., additional, McCluggage, W.G., additional, McNeish, I., additional, Morice, P., additional, Pignata, S., additional, Ray-Coquard, I., additional, Vergote, I., additional, Baert, T., additional, Belaroussi, I., additional, Dashora, A., additional, Olbrecht, S., additional, Planchamp, F., additional, Querleu, D., additional, Banerjee, S., additional, Blecharz, P., additional, Bruchim, I., additional, Cibula, D., additional, Colombo, N., additional, Concin, N., additional, Davidson, B., additional, Devouassoux-Shisheboran, M., additional, Ferrero, A., additional, Glasspool, R., additional, González-Martin, A., additional, Heinzelmann-Schwarz, V., additional, Joly, F., additional, Kim, J.W., additional, Kridelka, F., additional, Lorusso, D., additional, Mahner, S., additional, Mikami, M., additional, Mirza, M.R., additional, Nicum, S., additional, O’Donnell, D.M., additional, Pautier, P., additional, Rodolakis, A., additional, Sehouli, J., additional, Selcukbiricik, F., additional, Singh, N., additional, Tan, D.S.P., additional, Timmerman, D., additional, Tognon, G., additional, van der Velden, J., additional, Witteveen, P.O., additional, and Zeimet, A.G., additional

Published
2019
Full Text
View/download PDF

38. ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease

Author

Colombo, N., Sessa, C., du Bois, A., Ledermann, J., McCluggage, W. G., McNeish, I., Morice, P., Pignata, S., Ray-Coquard, I., Vergote, I., Baert, T., Belaroussi, I., Dashora, A., Olbrecht, S., Planchamp, F., Querleu, D., Banerjee, S., Blecharz, P., Bruchim, I., Cibula, D., Concin, N., Davidson, B., Devouassoux-Shisheboran, M., Ferrero, A., Glasspool, R., Gonzalez-Martin, A., Heinzelmann-Schwarz, V., Joly, F., Kim, J. W., Kridelka, F., Lorusso, D., Mahner, S., Mikami, M., Mirza, M. R., Nicum, S., O'Donnell, D. M., Pautier, P., Rodolakis, A., Sehouli, J., Selcukbiricik, F., Singh, N., Tan, D. S. P., Timmerman, D., Tognon, G., van der Velden, J., Witteveen, P. O., Zeimet, A. G., Colombo, N., Sessa, C., du Bois, A., Ledermann, J., McCluggage, W. G., McNeish, I., Morice, P., Pignata, S., Ray-Coquard, I., Vergote, I., Baert, T., Belaroussi, I., Dashora, A., Olbrecht, S., Planchamp, F., Querleu, D., Banerjee, S., Blecharz, P., Bruchim, I., Cibula, D., Concin, N., Davidson, B., Devouassoux-Shisheboran, M., Ferrero, A., Glasspool, R., Gonzalez-Martin, A., Heinzelmann-Schwarz, V., Joly, F., Kim, J. W., Kridelka, F., Lorusso, D., Mahner, S., Mikami, M., Mirza, M. R., Nicum, S., O'Donnell, D. M., Pautier, P., Rodolakis, A., Sehouli, J., Selcukbiricik, F., Singh, N., Tan, D. S. P., Timmerman, D., Tognon, G., van der Velden, J., Witteveen, P. O., and Zeimet, A. G.

Published
2019

39. ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease

Author

DDOD, Arts-assistenten Radiotherapie, MS Medische Oncologie, Cancer, Colombo, N., Sessa, C., du Bois, A., Ledermann, J., McCluggage, W. G., McNeish, I., Morice, P., Pignata, S., Ray-Coquard, I., Vergote, I., Baert, T., Belaroussi, I., Dashora, A., Olbrecht, S., Planchamp, F., Querleu, D., Banerjee, S., Blecharz, P., Bruchim, I., Cibula, D., Concin, N., Davidson, B., Devouassoux-Shisheboran, M., Ferrero, A., Glasspool, R., Gonzalez-Martin, A., Heinzelmann-Schwarz, V., Joly, F., Kim, J. W., Kridelka, F., Lorusso, D., Mahner, S., Mikami, M., Mirza, M. R., Nicum, S., O'Donnell, D. M., Pautier, P., Rodolakis, A., Sehouli, J., Selcukbiricik, F., Singh, N., Tan, D. S. P., Timmerman, D., Tognon, G., van der Velden, J., Witteveen, P. O., Zeimet, A. G., DDOD, Arts-assistenten Radiotherapie, MS Medische Oncologie, Cancer, Colombo, N., Sessa, C., du Bois, A., Ledermann, J., McCluggage, W. G., McNeish, I., Morice, P., Pignata, S., Ray-Coquard, I., Vergote, I., Baert, T., Belaroussi, I., Dashora, A., Olbrecht, S., Planchamp, F., Querleu, D., Banerjee, S., Blecharz, P., Bruchim, I., Cibula, D., Concin, N., Davidson, B., Devouassoux-Shisheboran, M., Ferrero, A., Glasspool, R., Gonzalez-Martin, A., Heinzelmann-Schwarz, V., Joly, F., Kim, J. W., Kridelka, F., Lorusso, D., Mahner, S., Mikami, M., Mirza, M. R., Nicum, S., O'Donnell, D. M., Pautier, P., Rodolakis, A., Sehouli, J., Selcukbiricik, F., Singh, N., Tan, D. S. P., Timmerman, D., Tognon, G., van der Velden, J., Witteveen, P. O., and Zeimet, A. G.

Published
2019

40. ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease

Author

Selçukbiricik, Fatih, Colombo, N.; Sessa, C.; du Bois, A.; Ledermann, J.; McCluggage, W. G.; McNeish, I.; Morice, P.; Pignata, S.; Ray-Coquard, I.; Vergote, I.; Baert, T.; Belaroussi, I.; Dashora, A.; Olbrecht, S.; Planchamp, F.; Querleu, D.; Baert, T.; Banerjee, S.; Belaroussi, I.; Blecharz, P.; Bruchim, I.; Cibula, D.; Colombo, N.; Concin, N.; Davidson, B.; Dashora, A.; Devouassoux-Shisheboran, M.; du Bois, A.; Ferrero, A.; Glasspool, R.; Gonzalez-Martin, A.; Heinzelmann-Schwarz, V.; Joly, F.; Kim, J. W.; Kridelka, F.; Ledermann, J.; Lorusso, D.; Mahner, S.; McCluggage, W. G.; McNeish, I.; Mikami, M.; Mirza, M. R.; Morice, P.; Nicum, S.; Olbrecht, S.; O'Donnell, D. M.; Pautier, P.; Planchamp, F.; Pignata, S.; Querleu, D.; Ray-Coquard, I.; Rodolakis, A.; Sehouli, J.; Selcukbiricik, F.; Sessa, C.; Singh, N.; Tan, D. S. P.; Timmerman, D.; Tognon, G.; van der Velden, J.; Vergote, I.; Witteveen, P. O.; Zeimet, A. G., Koç University Hospital, Selçukbiricik, Fatih, Colombo, N.; Sessa, C.; du Bois, A.; Ledermann, J.; McCluggage, W. G.; McNeish, I.; Morice, P.; Pignata, S.; Ray-Coquard, I.; Vergote, I.; Baert, T.; Belaroussi, I.; Dashora, A.; Olbrecht, S.; Planchamp, F.; Querleu, D.; Baert, T.; Banerjee, S.; Belaroussi, I.; Blecharz, P.; Bruchim, I.; Cibula, D.; Colombo, N.; Concin, N.; Davidson, B.; Dashora, A.; Devouassoux-Shisheboran, M.; du Bois, A.; Ferrero, A.; Glasspool, R.; Gonzalez-Martin, A.; Heinzelmann-Schwarz, V.; Joly, F.; Kim, J. W.; Kridelka, F.; Ledermann, J.; Lorusso, D.; Mahner, S.; McCluggage, W. G.; McNeish, I.; Mikami, M.; Mirza, M. R.; Morice, P.; Nicum, S.; Olbrecht, S.; O'Donnell, D. M.; Pautier, P.; Planchamp, F.; Pignata, S.; Querleu, D.; Ray-Coquard, I.; Rodolakis, A.; Sehouli, J.; Selcukbiricik, F.; Sessa, C.; Singh, N.; Tan, D. S. P.; Timmerman, D.; Tognon, G.; van der Velden, J.; Vergote, I.; Witteveen, P. O.; Zeimet, A. G., and Koç University Hospital

Abstract

The development of guidelines recommendations is one of the core activities of the European Society for Medical Oncology (ESMO) and European Society of Gynaecologial Oncology (ESGO), as part of the mission of both societies to improve the quality of care for patients with cancer across Europe. ESMO and ESGO jointly developed clinically relevant and evidence-based recommendations in several selected areas in order to improve the quality of care for women with ovarian cancer. The ESMO-ESGO consensus conference on ovarian cancer was held on 12-14 April 2018 in Milan, Italy, and comprised a multidisciplinary panel of 40 leading experts in the management of ovarian cancer. Before the conference, the expert panel worked on five clinically relevant questions regarding ovarian cancer relating to each of the following four areas: pathology and molecular biology, early-stage and borderline tumours, advanced stage disease and recurrent disease. Relevant scientific literature, as identified using a systematic search, was reviewed in advance. During the consensus conference, the panel developed recommendations for each specific question and a consensus was reached. The recommendations presented here are thus based on the best available evidence and expert agreement. This article presents the recommendations of this ESMO-ESGO consensus conference, together with a summary of evidence supporting each recommendation., ESMO and ESGO funds

Published
2019

43. The immune microenvironment of HPV-negative oral squamous cell carcinoma from never-smokers and never-drinkers patients suggests higher clinical benefit of IDO1 and PD1/PD-L1 blockade

Author

UCL - SSS/DDUV - Institut de Duve, Foy, J-P., Bertolus, C., Michallet, M-C., Deneuve, S., Incitti, R., Bendriss-Vermare, N., Albaret, M-A., Ortiz-Cuaran, S., Thomas, E., Colombe, A., Py, C., Gadot, N, Michot, J-P., Fayette, J., Viari, A., Van den Eynde, Benoît, Goudot, P., Devouassoux-Shisheboran, M., Puisieux, A., Caux, C., Zrounba, P., Lantuejoul, S., Saintigny, P., UCL - SSS/DDUV - Institut de Duve, Foy, J-P., Bertolus, C., Michallet, M-C., Deneuve, S., Incitti, R., Bendriss-Vermare, N., Albaret, M-A., Ortiz-Cuaran, S., Thomas, E., Colombe, A., Py, C., Gadot, N, Michot, J-P., Fayette, J., Viari, A., Van den Eynde, Benoît, Goudot, P., Devouassoux-Shisheboran, M., Puisieux, A., Caux, C., Zrounba, P., Lantuejoul, S., and Saintigny, P.

Published
2017

44. Extracranial Cephalic Schwannomas

Author

Torossian Jm, Beziat Jl, Devouassoux-Shisheboran M, G. Fischer, and Abou Chebel N

Subjects
Adult, Male, medicine.medical_specialty, Adolescent, Enucleation, Schwannoma, Epineurium, Humans, Medicine, Cranial Nerve Neoplasms, Sex Ratio, Neurofibromatosis, Child, Aged, Trigeminal nerve, medicine.diagnostic_test, business.industry, Soft tissue, Magnetic resonance imaging, General Medicine, Middle Aged, medicine.disease, Magnetic Resonance Imaging, medicine.anatomical_structure, Otorhinolaryngology, Head and Neck Neoplasms, Orbital Neoplasms, Female, Surgery, Radiology, Tomography, X-Ray Computed, business, Operating microscope, Neurilemmoma
Abstract

The aim of this study was to report a series of extracranial cephalic schwannomas. Fifteen patients with extracranial schwannomas treated between 1981 and 1999 are presented, and their clinical course during a median follow-up of 4.1 years is discussed. There is a female predominance. No specific factors have been identified. Their diagnosis is often delayed (median, 2.6 years). There is no predominant side. The orbit represents the most frequent location of schwannomas (26%). The trigeminal nerve is the most often affected (53%). Computed tomography and magnetic resonance imaging contribute to the diagnosis. Macroscopically, the schwannoma is a well-defined tumor of ovoid form and brownish color. It is formed of soft tissues and is fragmented easily. Diagnosis is often evident on microscopic examination. The only treatment is surgery. It consists of enucleation after opening the epineurium using an operating microscope, without interruption of the continuity of the nerve. The authors have observed only two relapses (the first two patients operated without a microscope). Total excision allows recovery. Nerve injuries have variable prognosis. It is necessary in juvenile populations to search for neurofibromatosis. All schwannomas required surgical treatment using an operating microscope to obtain total recovery.

Published
1999
Full Text
View/download PDF

46. 2705 The French National Network dedicated to Ovarian Malignant Rare Tumors (TMRO): How this organization changed management over the time for rare cancers

Author

Pautier, P., primary, Selle, F., additional, Devouassoux-Shisheboran, M., additional, Treilleux, I., additional, Floquet, A., additional, Croce, S., additional, Ferron, G., additional, Mery-Lamarche, E., additional, Pomel, C., additional, Penault-Llorca, F., additional, Leblanc, E., additional, Lefeuvre-Plesse, C., additional, Henno, S., additional, Joly, F., additional, Nadeau, C., additional, Dubois-Gordeeff, A., additional, Chiannilkulchai, N., additional, Genestie, C., additional, and Vacher-Lavenu, M.C., additional

Published
2015
Full Text
View/download PDF

47. Multidisciplinary management of advanced ovarian cancer for an optimal therapeutic strategy.

Author

Heudel, P. E., Devouassoux-Shisheboran, M., Taieb, S., Genestie, C., Selle, F., Morice, P., Rouzier, R., and Ray-Coquard, I.

Subjects
*OVARIAN cancer, *COMPUTED tomography, *CYTOREDUCTIVE surgery, *GYNECOLOGIC cancer, *INTERDISCIPLINARY research
Abstract

The management of advanced ovarian cancer generally requires specialist multidisciplinary teamwork to achieve optimum outcomes. Preoperative computed tomography scans are the imaging modality of choice in determining the extent of disease and aiding in surgical planning. Histological classification is crucial to define various subtypes with their different behaviour and prognosis and to plan the best therapeutic strategy. Pathological prognostic factors, such as histological type, degree of differentiation, and FIGO stage must be described. To determine the ability to optimally cytoreduce advanced ovarian cancer, an experienced gynaecological oncologist needs to explore the entire upper abdomen and the pelvic and para-aortic lymph node regions to define the peritoneal cancer index (PCI). The final assessment is the completeness of cytoreduction (CC) score which is important in predicting prognosis and decision of post-surgical surgery. Ovarian cancer is the leading cause of death from gynaecologic cancers. Initial management is best provided by a specialist multidisciplinary team, including a radiologist, a pathologist, a gynaecologic oncologist, and a medical oncologist. [ABSTRACT FROM AUTHOR]

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results